Open access · OA
via OpenAlex
STAT3 inhibition of gluconeogenesis is downregulated by SirT1
Yongzhan Nie, Derek M. Erion, Zhenglong Yuan, Marcelo O. Dietrich, Gerald I. Shulman, Tamás L. Horváth, Qian Gao
Nature Cell Biology · 2009 · ▲ 334 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/ncb1857
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Nie, Y., Erion, D.M., Yuan, Z., Dietrich, M.O., Shulman, G.I., Horváth, T.L., & Gao, Q. (2009). STAT3 inhibition of gluconeogenesis is downregulated by SirT1. <em>Nature Cell Biology</em>. https://doi.org/10.1038/ncb1857
Vancouver
Nie Y, Erion DM, Yuan Z, Dietrich MO, Shulman GI, Horváth TL, et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nature Cell Biology. 2009. doi:10.1038/ncb1857.
BibTeX
@article{yongzhan2009STATin,
title = {STAT3 inhibition of gluconeogenesis is downregulated by SirT1},
author = {Yongzhan Nie and Derek M. Erion and Zhenglong Yuan and Marcelo O. Dietrich and Gerald I. Shulman and Tamás L. Horváth and Qian Gao},
journal = {Nature Cell Biology},
year = {2009},
doi = {10.1038/ncb1857},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Archives of Pharmacal Research 2013
Citation only
Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy
Nature Cell Biology 2020
Preprint · OA
SIRT1 is downregulated by autophagy in senescence and ageing
Preventive Medicine 2011
Preprint · OA
SIRT1 as a therapeutic target in inflammaging of the pulmonary disease
Pharmacology & Therapeutics 2012
Citation only
SIRT1 in metabolic syndrome: Where to target matters
Environmental Research 2017
Open access · CC-BY
Cigarette smoking and telomere length: A systematic review of 84 studies and meta-analysis
Mutation research. Fundamental and molecular mechanisms of mutagenesis 2011
Citation only